This content was funded by an unrestricted educational grant from Shionogi Inc. (U.S.).
Even in 2026, SARS-CoV-2 transmission remains a real-world challenge in primary care, especially within households and high-contact settings. This webinar focuses on the prevention gap after exposure, where current post-exposure approaches can fall short, and why testing and timing are make-or-break constraints.
Uncover
- How exposure risk and urgency can differ across group homes, assisted living, care homes, and other congregate living
- Why clinical applicability is broad, including older adults, immunocompromised people, and those with underlying respiratory illnesses
- The importance of indirect populations including household members and healthcare workers who may transmit infection to vulnerable individuals
- Practical takeaways on testing to help avoid losing time after exposure
- How the PEP evidence landscape is evolving
Speakers:
Stefan Gravenstein1
Lynn McNicoll2
1. Division of Geriatrics and Palliative Medicine, Brown University, Providence, Rhode Island, USA
2. Division of Geriatrics, Brown University,Providence, Rhode Island, USA


